Urgent Reminder for Agenus Inc. Investors About Class Action Deadline
If you’ve invested in Agenus Inc., it’s time to pay attention to an important deadline related to a class action lawsuit concerning securities fraud. As a shareholder, it’s essential to know your rights and the steps you can take as this deadline approaches.
Your Involvement Matters
Did you own shares in Agenus Inc. (NASDAQ: AGEN) at any point? If the answer is yes, it’s worth reflecting on your investment during the specified period. Specifically, did you buy shares between January 23, 2023, and July 17, 2024? This timeframe pertains directly to the lawsuit.
Assessing Your Investment
It's crucial to evaluate whether your investment in Agenus has brought you profits or losses. If you’ve suffered losses, now may be a good time to consider your legal options. Speaking to an experienced attorney could offer you valuable insights into your circumstances.
Bernstein Liebhard LLP’s Involvement
Bernstein Liebhard LLP, a prominent firm dedicated to investor rights, is reminding all shareholders of Agenus about the ongoing lawsuit. With a proven history of advocating for individuals in similar situations, the firm focuses on helping those affected recover their lost investments.
Details About the Lawsuit
This lawsuit addresses alleged misrepresentations made by the Company regarding its investigational therapy targeting metastatic colorectal cancer. Shareholders interested in this class action can participate by submitting the necessary documentation by November 5, 2024.
What Shareholders Need to Do
For those considering stepping up as lead plaintiffs, it's vital to submit the necessary paperwork on time. Serving as a lead plaintiff means you'd take on a role directing the litigation for other investors. However, if you prefer to remain anonymous, you can still join as an absent class member, which allows you to share in any potential recovery from the lawsuit.
No Upfront Costs
If you’re worried about expenses, Bernstein Liebhard LLP works on a contingency fee structure. This means you won’t pay any upfront fees or costs unless you win your case. This approach prioritizes the interests of shareholders.
Bernstein Liebhard LLP’s Success
Since its establishment in 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients, demonstrating its commitment and expertise in litigation. The firm is dedicated not only to individual investors but also collaborates with large pension funds to protect their financial interests.
Investor Contact Information
If you’re an Agenus investor seeking more information about the class action, connecting with Investor Relations Manager Peter Allocco could be a key next step. You can reach him at (212) 951-2030; he’s ready to help with any questions you might have about your rights or the class action process.
Frequently Asked Questions
1. What is the objective of the class action lawsuit against Agenus Inc.?
The lawsuit aims to address claims of securities fraud related to misstatements made regarding their investigational therapy.
2. How can I determine if I'm among the affected shareholders?
If you purchased shares between January 23, 2023, and July 17, 2024, you may qualify to be part of this class action.
3. What are the consequences of missing the deadline?
If you fail to file your paperwork by the deadline, you might lose your chance to be involved in the settlement.
4. Will there be any costs to join the class action?
There are no upfront fees required; the firm works on a contingency basis.
5. Who can I contact to learn more?
For further questions regarding your rights or the class action, you can contact Peter Allocco at Bernstein Liebhard LLP.
